Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

A-131701: a uroselective alpha-adrenergic agent for treatment of BPH

Aug. 27, 1998

GG-745: a 5alpha-reductase inhibitor with significant advantages over finasteride

Aug. 27, 1998

Antimuscarinic agent KRP-197 shows potential for treating incontinence

Aug. 24, 1998

HMR-4902 protects against acute renal failure in rats

Aug. 20, 1998

Kissei studies beta-adrenergic drug for use in patients with urolithiasis

Aug. 18, 1998

New compound for urinary incontinence poised to enter clinical testing at Recordati

Aug. 14, 1998

AH-9700, a promising centrally and peripherally acting treatment for incontinence

Aug. 13, 1998

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Aug. 11, 1998

Takeda patents tachykinin antagonists and their use in urinary disorders

July 30, 1998

Dainippon claims series with potential for urinary incontinence

July 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...